World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02272582
Date of registration: 15/10/2014
Prospective Registration: No
Primary sponsor: Perrault Louis P.
Public title: A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing CABG (STEPS) GALA
Scientific title: A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing Coronary Artery Bypass Grafting (CABG)
Date of first enrolment: September 24, 2014
Target sample size: 100
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02272582
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Name:     Louis P Perrault, MD
Address: 
Telephone:
Email:
Affiliation:  Montreal Heart Institute
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patient is to undergo primary, multi-vessel CABG with at least two saphenous vein
grafts (SVGs)

Exclusion Criteria:

- Patient has in-situ Internal Mammary Artery graft(s) (IMA) only, (no SVG or free
arterial grafts)

- Patients has had prior CABG or planned concomitant valve surgery or aortic aneurysm
repair.



Age minimum: 18 Years
Age maximum: 80 Years
Gender: All
Health Condition(s) or Problem(s) studied
Coronary Artery Disease
Intervention(s)
Device: SOMVC001 Vascular Conduit Solution
Other: Standard of care Heparin-dosed saline
Primary Outcome(s)
Mean wall thickness of paired grafts within 100 participants measured at 4-6 weeks and 3 months post-CABG surgery using 64-slice multidetector computed tomography (MDCT) angiography. [Time Frame: 4-6 weeks to 3 months]
Secondary Outcome(s)
Secondary ID(s)
003-03
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Montreal Heart Institute
Somahlution LLC
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history